Antibody Response of Combination of BNT162b2 and CoronaVac Platforms of COVID-19 Vaccines against Omicron Variant

By vaccinating SARS-CoV-2 naïve individuals who have already received two doses of COVID-19 vaccines, we aimed to investigate whether a heterologous prime-boost strategy, using vaccines of different platforms as the booster dose, can enhance the immune response against SARS-CoV-2 virus variants. Par...

Descripción completa

Detalles Bibliográficos
Autores principales: Khong, Ka-Wa, Liu, Danlei, Leung, Ka-Yi, Lu, Lu, Lam, Hoi-Yan, Chen, Linlei, Chan, Pui-Chun, Lam, Ho-Ming, Xie, Xiaochun, Zhang, Ruiqi, Fan, Yujing, To, Kelvin Kai-Wang, Chen, Honglin, Yuen, Kwok-Yung, Chan, Kwok-Hung, Hung, Ivan Fan-Ngai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877145/
https://www.ncbi.nlm.nih.gov/pubmed/35214619
http://dx.doi.org/10.3390/vaccines10020160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877145/
https://www.ncbi.nlm.nih.gov/pubmed/35214619
http://dx.doi.org/10.3390/vaccines10020160

Ejemplares similares